SonoScape Medical Corp. (300633.SZ)
CNY 31.8
(-0.31%)
CNY 31.8
(-0.31%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 2.12 Billion CNY | 20.29% |
| 2022 | 1.76 Billion CNY | 22.02% |
| 2021 | 1.44 Billion CNY | 24.2% |
| 2020 | 1.16 Billion CNY | -7.24% |
| 2019 | 1.25 Billion CNY | 2.2% |
| 2018 | 1.22 Billion CNY | 24.04% |
| 2017 | 989.06 Million CNY | 37.49% |
| 2016 | 719.35 Million CNY | 4.89% |
| 2015 | 685.82 Million CNY | 7.21% |
| 2014 | 639.72 Million CNY | 8.02% |
| 2013 | 592.24 Million CNY | 22.3% |
| 2012 | 484.24 Million CNY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 474.98 Million CNY | -27.2% |
| 2024 Q2 | 533.35 Million CNY | 12.29% |
| 2024 Q3 | 385.5 Million CNY | -27.72% |
| 2023 Q4 | 652.41 Million CNY | 53.69% |
| 2023 FY | 2.12 Billion CNY | 20.29% |
| 2023 Q2 | 570.3 Million CNY | 20.56% |
| 2023 Q3 | 424.49 Million CNY | -25.57% |
| 2023 Q1 | 473.03 Million CNY | -7.5% |
| 2022 Q4 | 511.36 Million CNY | 22.99% |
| 2022 Q2 | 464.89 Million CNY | 25.44% |
| 2022 Q1 | 370.62 Million CNY | -26.53% |
| 2022 FY | 1.76 Billion CNY | 22.02% |
| 2022 Q3 | 415.75 Million CNY | -10.57% |
| 2021 FY | 1.44 Billion CNY | 24.2% |
| 2021 Q1 | 281.78 Million CNY | -37.49% |
| 2021 Q2 | 360.94 Million CNY | 28.09% |
| 2021 Q4 | 504.46 Million CNY | 69.63% |
| 2021 Q3 | 297.39 Million CNY | -17.61% |
| 2020 Q4 | 450.81 Million CNY | 99.36% |
| 2020 Q3 | 226.12 Million CNY | -10.22% |
| 2020 Q2 | 251.85 Million CNY | 7.5% |
| 2020 Q1 | 234.28 Million CNY | -49.53% |
| 2020 FY | 1.16 Billion CNY | -7.24% |
| 2019 FY | 1.25 Billion CNY | 2.2% |
| 2019 Q4 | 464.16 Million CNY | 89.31% |
| 2019 Q2 | 314.59 Million CNY | 36.83% |
| 2019 Q1 | 229.91 Million CNY | -47.04% |
| 2019 Q3 | 245.18 Million CNY | -22.06% |
| 2018 Q3 | 252.21 Million CNY | -18.55% |
| 2018 Q4 | 434.13 Million CNY | 72.13% |
| 2018 FY | 1.22 Billion CNY | 24.04% |
| 2018 Q1 | 230.85 Million CNY | -34.2% |
| 2018 Q2 | 309.64 Million CNY | 34.13% |
| 2017 Q3 | 214.48 Million CNY | -18.74% |
| 2017 Q1 | 159.82 Million CNY | -50.85% |
| 2017 FY | 989.06 Million CNY | 37.49% |
| 2017 Q2 | 263.93 Million CNY | 65.14% |
| 2017 Q4 | 350.82 Million CNY | 63.57% |
| 2016 Q2 | 163.57 Million CNY | 72.65% |
| 2016 FY | 719.35 Million CNY | 4.89% |
| 2016 Q4 | 325.15 Million CNY | 139.27% |
| 2016 Q3 | 135.89 Million CNY | -16.92% |
| 2016 Q1 | 94.73 Million CNY | 0.0% |
| 2015 Q1 | 130.72 Million CNY | 0.0% |
| 2015 FY | 685.82 Million CNY | 7.21% |
| 2014 FY | 639.72 Million CNY | 8.02% |
| 2013 FY | 592.24 Million CNY | 22.3% |
| 2012 FY | 484.24 Million CNY | 0.0% |